Simplifying Global Compliance
Company Warned for Noncompliance on Clinical Trial Protocol, Protections
Devices & Diagnostics Letter
The FDA handed Atlanta-based CardioMEMS a warning letter for numerous deviations related to a clinical investigation and PMA for its CardioMEMS HF Pressure Measurement System.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing